very excited momentum built past you with fourth XXXX throughout some strong the quarter both you year for by all XX everyone. us I'm achievements XXXX good so of a the well the Cam, we're for to the will our measures, in future. was, as company. the confident significant our Thank you, as months to I'm Thank call. share conference XXXX. numerous and that reasons joining excited continue year morning for on our over
We As of Tom fourth will can has XXXX quarter grew revenue increased while detail, in safely year XXXX, a review exceeded ALLY compared the year revenue since expectations. revenue in in history. compared marking to also greater to in quarter I launching full our XX% placed first say a placements mid-third also ALLY company's significant highest from total the XXXX full competitive the annual XX% our and that to ago, that surgeons were systems of last majority placements to XX of have converted above year of initial guidance devices. our commercial launch. XX% It of in new LENSAR, with half sites XX year a XXXX is note, approximately our to
our only installed ALLY to legacy total the next-generation LLS. we XX% available in systems, our approximately and comprising U.S., significant currently the was is base virtually worldwide being ongoing market. ALLY grew Although cataract This premium growth XXX previously a both nonexistent in in Korea, payers was achieved care issues robust dispute has resulted health South an third-party in and procedures whereby despite what providers by between
increased revenue revenue our total focus you growth South XX% XXXX. compared on to without If Korea, XXXX
over installed base the we're is consider performance grew to percentage this if growth even the strong event. U.S. currently Accordingly, a impressive our ALLY's in in more fact U.S. again, limited XX%, any you installing Once that
of ALLY X year in robust to systems we Importantly, with ahead. convert pipeline demand we the for XXXX the potential a of working are technology remains finish as that backlog customers strong diligently and a
utilization encouraging our the year installed in report to increasing X% highly to year compared volume over XX% growth XXXX ago procedure addition the procedures fourth full In nearly and we to quarter trends period. strong with base, up continue
of revenue been you down Similar which story, effect when the has Korea, even year our to South shut full more since procedure mid-'XX. growth essentially the exclude becomes impressive
South Backing for 'XX activity worldwide volumes our year. over 'XX, procedure last XX% Korea out both and increased
to their offers to comfort We will the continue value customers practice. and as well These increased that and the they grow, benefits utilization our ergonomic within see with to platform demonstrate speed, efficiency benefits with management of overall adoption ALLY further performance, as levels drive surgeons ALLY continue the significant primarily astigmatism create technologies. firsthand can our as compared legacy
to considering the continues matter competitive and increasingly but gets a replace the upgrade. those this utilization time their to become credible will installed time Again, to devices sources of our ALLY. for As really with technology right replaced the expand, peer-to-peer if is referrals is optimal are when base not that older
staff spending minutes up and X recently minutes the in a time studies less manually this to number model and can patient. surgeons facility save surgical up To with up completed time LenSx a laser and Ultimately, marking motion interactions save compared performance case patients workflows streamlining to to ALLY using Staff can result per XX of efficiencies that the and minutes to using reducing with preoperatively. as in to patient workflow that X ALLY end, we case. can in by and determined XX per ASCs different due
generating scope Using of OR per day day where and rates in their and very average XXX surgeons staff ASC to $XX,XXX can $X,XXX average per centers astigmatism day treat time more saving performing year. minutes and data average incisions patient schedules, managing market up of revenue and surgical an or XX to the CMS $XXX,XXX conversion can year. end to consideration, charge per additional patients, choose up per $XXX,XXX for and surgeons capacity is to payment earlier, Alternatively, astigmatic busy the per
solid to company proposition, on $XX,XXX can ASCs fees $XXX,XXX big compelling in return a makes additional and very costs staff day, providing where This alternative While per and facility bundles. a per an garner investment year. ALLY value the
surgical is and in our belief emerge surgeons, see, the experience solution for ALLY device can long-standing of patients. and support to a technology to you that staff cataract overall offers beginning better independent optimize As data
the market growth last context broader story. quarter, X.X% the the XX.X% launching the according its exciting marks fourth in market tells U.S. looking share share quarter own, primary the consecutive since similarly on In of to in at reached scope. sector we've the and of our over This a in promising our While year it a market delivered ALLY gains U.S. in is our representing seventh geography gain
patients. a are of suited, to are significant is XX% cataract be X% average number X%. cataract is with laser-assisted per significant the with XX% surgeons, The our approaching year. population of data provides higher organic for that technology data, currently has that expected growth strong use XX% between on recognized in the growth year-over-year and organic a in aging all benefits achieve on potential LENSAR there expectation X% growth foreseeable future. support ideally ALLY affects for which based the Additionally, to patients plus and end cataract staff and competitive contributing benefit of for represent annual surgeries life. to combined Visually Demographics ALLY rate This plus femtosecond astigmatism and to surgery an systems growth of of
is outlined, date are and anticipated clinical in to but contribution not the ALLY for efficiencies and their by making significant only growth as fueled also business patients. ALLY's this surgeons growth previously Our opportunities
outcomes X better now demonstrating alignment in peer that IOL we LENSAR's [ surgeons astigmatic Specifically, to toric the patients. papers astigmatic Tele proprietary guide ] have deliver to and guiding of review and create superiority Access technology enables incisions their
intraocular IntelliAxis Cataract the The Callisto registration their Bochum, tool significant in statistically Refractive published and IRIS lenses ZEISS using those outcomes professors most technology using to astigmatism for review IntelliAxis compared Refractive of and Tim cataract with surgery Ruhr Burkhard this axis in align the Hospital of Eye was to LENSAR Journal Dick, and found University that renowned where recent peer their in improvements the Schultz, patients. another the MD MD compared guided Germany, from outcomes called from paper Capsulorhexis month alignment toric
to there outlook specific optimistic related the are Turning multiple for reasons and to We beyond. LENSAR believe to XXXX market. broader both and that be our to
despite we've freeze this achieved Korea. growth the meaningful continued South First, in
for when clearly, it's QX the matter might but of if it was the X to We and reopen, X a quarters. Revenue market speculate can't not when happens. following as essentially after
South However, the role play bigger in particularly question will of is Korea terms once our a future growth, when it how does, available. significant is ALLY
South and XX.X% respectively. put Korea service compares perspective, less our To product in 'XX in it service product revenue 'XX, X.X% fiscal our to of revenue XXXX. and X% in and and of represented This than
the will market the that end be Our stated resolved, are of to size the prior third-party shutdown. be it the a payer roughly was issues when result market that estimated to distributor XX%
the in for for later we available currently this States, decision is in submitted ahead. year expect the ALLY and We year. Union the evolve European ALLY to this XXXX, only reminder, a on certification Mark United certification a As we of expect in September use but in CE
by they quickly Our is distributors marketing for witnessing being importantly, their authorization. ALLY available and distributors many and surgeons adaptive ophthalmic patients. excited we more the serve. international to significant surgeons the well once within are are the our results experience make treatment of for and system American European extends of equipped to receive achieved benefit surgeons the ALLY eager Enthusiasm and to ALLY beyond community advantages firsthand the to the cataract counterparts the These practices are their
an market in our significant approaching favorable we're positioned and into a come. for footprint combining I the through storm, global to perfect regulatory expanded industry dynamics conditions. to of innovation, believe that years geographic new world-class We're been market translate we're -- clearances technology, well addressing which growth the improving to an ripe these has anticipation
the our and vision of a well a ALLY, reality. to we to objectives are have way on maximizing We that set of on say focused clear I'm making proud success our
Tom the our to the turn Now me Tom? call over year. financial quarter for let highlights and cover to
